Livzon Pharmaceutical Group Inc. (HKG:1513)
Hong Kong · Delayed Price · Currency is HKD 39.10
-0.40 (-1.01%)
Jul 29, 2025, 4:08 PM HKT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Chemical Drug Preparations | 6.12B | Log In | Log In | Log In | Log In | Upgrade |
Chemical Drug Preparations Growth | -6.87% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates | 3.25B | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients and Intermediates Growth | 0.06% | Log In | Log In | Log In | Log In | Upgrade |
Traditional Chinese Medicine Preparations | 1.41B | Log In | Log In | Log In | Log In | Upgrade |
Traditional Chinese Medicine Preparations Growth | -19.27% | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Reagents and Equipment | 718.43M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostic Reagents and Equipment Growth | 9.02% | Log In | Log In | Log In | Log In | Upgrade |
Biological Products | 170.89M | Log In | Log In | Log In | Log In | Upgrade |
Biological Products Growth | 102.42% | Log In | Log In | Log In | Log In | Upgrade |
Other Activities | 52.01M | Log In | Log In | Log In | Log In | Upgrade |
Other Activities Growth | 5.18% | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials, Processing Charge, Etc. | 51.39M | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials, Processing Charge, Etc. Growth | 11.84% | Log In | Log In | Log In | Log In | Upgrade |
Lease | 8.33M | Log In | Log In | Log In | Log In | Upgrade |
Lease Growth | -7.97% | Log In | Log In | Log In | Log In | Upgrade |
Other | 28.52M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 108.69% | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials | - | Log In | Log In | Log In | Log In | Upgrade |
Sales Materials Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Processing | - | Log In | Log In | Log In | Log In | Upgrade |
Processing Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Power Supply | - | Log In | Log In | Log In | Log In | Upgrade |
Power Supply Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Technology Transfer | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gastrointestinal | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gastrointestinal Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Bulk Medicines and Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Bulk Medicines and Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gonadotropic Hormones | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Gonadotropic Hormones Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Antibiotics | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Antibiotics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Others | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Cardio-cerebral Vascular | - | Log In | Log In | Log In | Log In | Upgrade |
Western Drug Preparation Products - Cardio-cerebral Vascular Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
China | 9.98B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -7.23% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 1.72B | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 9.69% | Log In | Log In | Log In | Log In | Upgrade |